|
|
Volumn 192, Issue 5, 2014, Pages 823-824
|
|
CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLORIDE;
IVACAFTOR;
AMINOPHENOL DERIVATIVE;
CFTR PROTEIN, HUMAN;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
N-(2,4-DI-TERT-BUTYL-5-HYDROXYPHENYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE;
QUINOLONE DERIVATIVE;
RESPIRATORY TRACT AGENT;
ACHROMOBACTER XYLOSOXIDANS;
ADOLESCENT;
BACTERIUM ISOLATE;
BODY MASS;
CASE REPORT;
CHLORIDE BLOOD LEVEL;
COMPUTER ASSISTED TOMOGRAPHY;
CYSTIC FIBROSIS;
FEMALE;
FORCED EXPIRATORY VOLUME;
FORCED VITAL CAPACITY;
GENOTYPE;
HUMAN;
LUNG FUNCTION;
MALE;
METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS;
NOTE;
SPIROMETRY;
AGE;
AGONISTS;
CONVALESCENCE;
DRUG EFFECTS;
GENETIC PREDISPOSITION;
GENETICS;
LUNG;
MUTATION;
PATHOPHYSIOLOGY;
PHENOTYPE;
PREDICTIVE VALUE;
RADIOGRAPHY;
TIME;
TREATMENT OUTCOME;
VITAL CAPACITY;
ADOLESCENT;
AGE FACTORS;
AMINOPHENOLS;
CYSTIC FIBROSIS;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
FORCED EXPIRATORY VOLUME;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
LUNG;
MALE;
MUTATION;
PHENOTYPE;
PREDICTIVE VALUE OF TESTS;
QUINOLONES;
RECOVERY OF FUNCTION;
RESPIRATORY SYSTEM AGENTS;
TIME FACTORS;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
VITAL CAPACITY;
|
|
EID: 84907590323
PISSN: 03412040
EISSN: 14321750
Source Type: Journal
DOI: 10.1007/s00408-014-9629-y Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
